Health Advocate Highlights Challenges in Medical Cannabis Legalization in PH
The medical cannabis regulatory framework Philippines requires is crucial for patient safety and effective legalization. Concerns about regulatory infrastructure and enforcement remain central to the debate. This framework aims to balance access with…
Summary Since Last Update: Teen Brain Risk, Regulatory Crossroads, and the Veterans Cannabis Signal — February 24, 2026
This summary highlights teen cannabis use psychiatric risk data and its implications for neurodevelopment. Regulatory crossroads around hemp THC products in 2026 are also discussed. Additionally, veterans' cannabis use and emerging Medicare coverage are…
Horrifying Simulation Shows What Happens to Your Body If You Smoke Weed Every Day
Daily cannabis use risks include significant changes to brain development, particularly in adolescents. Research shows accelerated cortical thinning in the prefrontal cortex linked to heavy use. Understanding these risks helps clinicians provide better…
Can the Placenta Predict Schizophrenia Risk? Lessons from Prenatal Cannabis Exposure
Emerging research highlights placental genetic markers schizophrenia risk as potential early indicators of neurodevelopmental outcomes. Prenatal cannabis exposure may alter these markers, affecting fetal brain development. Understanding these changes is…
New Study Links Adolescent Cannabis Exposure to Psychosis Risk
Adolescent cannabis exposure psychosis risk is a critical concern supported by large-scale research. This study highlights the increased vulnerability to psychotic disorders linked to cannabis use during adolescence. Understanding this risk is vital for…
The Neuroscience of Cannabis Appetite Stimulation
Cannabis appetite stimulation neuroscience reveals how cannabinoids interact with the brain's endocannabinoid system to increase hunger. Activation of CB1 receptors in the hypothalamus and olfactory regions enhances food perception and overrides satiety.…
IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial
The Phase 2 CALMA trial expands clinical sites for cannabinoid-based therapy Alzheimer agitation, offering new hope for managing difficult symptoms. This cannabinoid-based therapy Alzheimer agitation approach targets neuroinflammation and behavioral…
Munchies Phenomenon: WSU Study Looks into Benefits of Cannabis Use and Appetite
Cannabis-induced appetite stimulation is a confirmed brain response that could help patients with HIV/AIDS and cancer. A WSU and University of Calgary study showed this effect occurs universally regardless of demographics. This research highlights the…
Full-Spectrum Cannabis Extract Shows Significant Pain Reduction in Chronic Neuropathic Pain
If you live with chronic nerve pain, this study provides clinical evidence that full-spectrum cannabis extract chronic neuropathic pain relief can deliver meaningful benefits. A clinical study found that a full-spectrum cannabis extract containing a…
New Study in Pullman Shows ‘Munchies’ Might Help Those with Loss of Appetite
A new Pullman study highlights cannabis-based appetite therapies using whole-plant vapor cannabis to help those with loss of appetite. The research involved 82 volunteers and showed a universal, immediate appetite effect. This study supports developing…